Cytori appoints David Rickey as chairman

San Diego-based Cytori Therapeutics has named David Rickey as the successor to its current chairman of the board Lloyd Dean.

Rickey brings more than a decade of experience with Cytori to the position, having served on the board of directors at the cell therapy-focused biotech for 13 years.

In addition to this role, he has served in several senior positions over the course of the past few years, primarily at technology companies.

This includes periods as president, CEO and chairman of Applied Micro Circuits Corporation; director of AMI Semiconductor; and director of Netlist.

His predecessor as Cytori chairman, Dean, will continue to serve as an independent member of the board of directors in addition to his role as president and CEO of healthcare provider Dignity Health.

According to Cytori, Dean requested the move to cope with Dignity Health's preparations for the implementation of the Affordable Care Act in the US in 2014.

“We are grateful to Mr Dean for his leadership and service as Chairman for the past two years, and look forward his continued service to Cytori and our shareholders into the future,” said Chris Calhoun, CEO of Cytori.